Yi Feng Chen

Yi Feng Chen practices at New Jersey Vein and Cosmetic Surgery in West Orange, New Jersey.

Yi Feng Chen's NPI, 1447518535, was assigned on April 26, 2012. Yi Feng Chen graduated from New York University School of Medicine in 2012. Yi Feng Chen holds Pennsylvania license MD483111.

Yi Feng Chen's primary practice is New Jersey Vein and Cosmetic Surgery, at 741 Northfield Ave - Suite 105, West Orange, NJ 07052. The practice phone is (732) 243-9729.

Yi Feng Chen's primary practice is New Jersey Vein and Cosmetic Surgery in West Orange, New Jersey. Yi Feng Chen is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is Associates in Otolaryngology of New Jersey. Dmand AI also links Yi Feng Chen to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yi Feng Chen practices, 5 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Yi Feng Chen's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Yi Feng Chen's licenses on file in 3 states: Pennsylvania, New Jersey and New York.

CMS data shows 3,656 Medicare services from Yi Feng Chen across 11 procedure codes in 2024, for 217 Medicare patients. Medicare paid $42,081 for them. Every service was in an office.

CMS counts 217 Medicare patients who saw Yi Feng Chen in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Yi Feng Chen's median patient age at 43, with 55% women.

In 2024, Yi Feng Chen wrote 632 Medicare Part D claims for 189 patients. 68% of them were for generic drugs. CMS names the drug for 479 of them, across 18 drugs with 11 or more claims each, at $45,354 in total drug cost. In 2023, CMS named 286 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Yi Feng Chen for performance year 2024, reported as part of a group. Yi Feng Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 421 general payments to Yi Feng Chen from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,073.

Yi Feng Chen graduated from New York University School of Medicine in 2012.